Acuta Capital Partners’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Sell |
37,070
-69,004
| -65% | -$6.94M | 5.21% | 7 |
|
|
2025
Q1 | $8.09M | Buy |
106,074
+1,274
| +1% | +$97.2K | 9.38% | 2 |
|
|
2024
Q4 | $7.24M | Sell |
104,800
-2,700
| -3% | -$186K | 7.28% | 2 |
|
|
2024
Q3 | $7.85M | Buy |
107,500
+35,400
| +49% | +$2.58M | 6.36% | 4 |
|
|
2024
Q2 | $4.83M | Buy |
72,100
+10,382
| +17% | +$696K | 4.07% | 10 |
|
|
2024
Q1 | $1.67M | Buy |
61,718
+32,218
| +109% | +$874K | 1.09% | 24 |
|
|
2023
Q4 | $914K | Buy |
+29,500
| New | +$914K | 0.51% | 32 |
|
|
2021
Q2 | – | Sell |
-42,500
| Closed | -$1.45M | – | 43 |
|
|
2021
Q1 | $1.45M | Buy |
+42,500
| New | +$1.45M | 0.52% | 39 |
|
|
2020
Q1 | – | Sell |
-169,000
| Closed | -$4.04M | – | 33 |
|
|
2019
Q4 | $4.04M | Sell |
169,000
-51,000
| -23% | -$1.22M | 1% | 24 |
|
|
2019
Q3 | $3.88M | Sell |
220,000
-215,500
| -49% | -$3.8M | 2.8% | 12 |
|
|
2019
Q2 | $11.1M | Buy |
435,500
+65,500
| +18% | +$1.68M | 3.96% | 10 |
|
|
2019
Q1 | $10.8M | Buy |
+370,000
| New | +$10.8M | 5.11% | 5 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 47 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 44 |
|
|
2016
Q3 | – | Sell |
-220,000
| Closed | -$2.17M | – | 58 |
|
|
2016
Q2 | $2.17M | Buy |
+220,000
| New | +$2.17M | 1.04% | 26 |
|
|
2015
Q2 | – | Sell |
-150,000
| Closed | -$3.12M | – | 53 |
|
|
2015
Q1 | $3.12M | Buy |
150,000
+136,846
| +1,040% | +$2.85M | 2.63% | 12 |
|
|
2014
Q4 | $203K | Buy |
+13,154
| New | +$203K | 0.14% | 51 |
|